The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer: Principles and Practice of Oncology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-819_4 · Cited by 8,516
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
WHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) · The Lancet · doi:10.1016/s0140-6736(11)60993-8 · Cited by 3,075
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
From Cancer Patient to Cancer Survivor: Lost in Transition
(2005) · PsycEXTRA Dataset · doi:10.1037/e720092007-001 · Cited by 2,285
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Nutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationCuzick, J., Sestak, I., Baum, M., Buzdar, A., Howell, A., Dowsett, M., & Forbes, J. F. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70257-6 · Cited by 1,674
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Attal, M., Lauwers-Cances, V., Marit, G., Caillot, D., Moreau, P., Facon, T., Stoppa, A. M., Hulin, C., Benboubker, L., Garderet, L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114138 · Cited by 1,155
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
McCarthy, P. L., Owzar, K., Hofmeister, C. C., Hurd, D. D., Hassoun, H., Richardson, P. G., Giralt, S., Stadtmauer, E. A., Weisdorf, D. J., Vij, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114083 · Cited by 1,147
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Solid Cancers after Bone Marrow Transplantation
Curtis, R. E., Rowlings, P. A., Deeg, H. J., Shriner, D. A., Socié, G., Travis, L. B., Horowitz, M. M., Witherspoon, R. P., Hoover, R. N., Sobocinski, K. A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703273361301 · Cited by 965
Self-citationBurke, W. (1997) · JAMA · doi:10.1001/jama.277.12.997 · Cited by 955
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000067 · Cited by 928
(2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70385-6 · Cited by 919
Coates, A. S., Keshaviah, A., Thürlimann, B., Mouridsen, H., Mauriac, L., Forbes, J. F., Paridaens, R., Castiglione-Gertsch, M., Gelber, R. D., Colleoni, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8617 · Cited by 910
Polygenic susceptibility to breast cancer and implications for prevention
Pharoah, P. D. P., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., & Ponder, B. A. J. (2002) · Nature Genetics · doi:10.1038/ng853 · Cited by 899
Chlebowski, R. T., Blackburn, G. L., Thomson, C. A., Nixon, D. W., Shapiro, A., Hoy, M. K., Goodman, M. T., Giuliano, A. E., Karanja, N., McAndrew, P., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj494 · Cited by 825
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Self-citationCollaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
Pierce, J. P., Natarajan, L., Caan, B. J., Parker, B. A., Greenberg, E. R., Flatt, S. W., Rock, C. L., Kealey, S., Al-Delaimy, W. K., Bardwell, W. A., et al. (2007) · JAMA · doi:10.1001/jama.298.3.289 · Cited by 734
Parsons, A., Daley, A., Begh, R., & Aveyard, P. (2010) · BMJ · doi:10.1136/bmj.b5569 · Cited by 696
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
Travis, L. B., Hill, D. A., Dores, G. M., Gospodarowicz, M., van Leeuwen, F. E., Holowaty, E., Glimelius, B., Andersson, M., Wiklund, T., Lynch, C. F., et al. (2003) · JAMA · doi:10.1001/jama.290.4.465 · Cited by 666
Self-citationSmith, R. A., Cokkinides, V., Brooks, D., Saslow, D., & Brawley, O. W. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20063 · Cited by 660
Lindor, N. M., Petersen, G. M., Hadley, D. W., Kinney, A. Y., Miesfeldt, S., Lu, K. H., Lynch, P., Burke, W., & Press, N. (2006) · JAMA · doi:10.1001/jama.296.12.1507 · Cited by 629
Neglia, J. P., Robison, L. L., Stovall, M., Liu, Y., Packer, R. J., Hammond, S., Yasui, Y., Kasper, C. E., Mertens, A. C., Donaldson, S. S., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj411 · Cited by 566
Dores, G. M., Metayer, C., Curtis, R. E., Lynch, C. F., Clarke, E. A., Glimelius, B., Storm, H., Pukkala, E., van Leeuwen, F. E., Holowaty, E. J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.038 · Cited by 565
Self-citationLung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Self-citationSecond primary neoplasms in patients with retinoblastoma
Draper, G. J., Sanders, B. M., & Kingston, J. E. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.110 · Cited by 554
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000.
Curtis, R. E., Freedman, D. M., Ron, E., Ries, L. A. G., Hacker, D. G., Edwards, B. K., Tucker, M., & Fraumeni, J. F. (2006) · Cited by 527
Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop, D. T. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.894 · Cited by 509
State of the epidemiological evidence on physical activity and cancer prevention
Friedenreich, C. M., Neilson, H. K., & Lynch, B. M. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.028 · Cited by 507
Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810818 · Cited by 496
Kleinerman, R. A., Tucker, M. A., Tarone, R. E., Abramson, D. H., Seddon, J. M., Stovall, M., Li, F. P., & Fraumeni, J. F. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.054 · Cited by 487
Gillison, M. L., Zhang, Q., Jordan, R., Xiao, W., Westra, W. H., Trotti, A., Spencer, S., Harris, J., Chung, C. H., & Ang, K. K. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4099 · Cited by 487
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
de Gonzalez, A. B., Curtis, R. E., Kry, S. F., Gilbert, E., Lamart, S., Berg, C. D., Stovall, M., & Ron, E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70061-4 · Cited by 481
Cancer: Principles and Practice of Oncology
Gunn, W. G. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03330090080041 · Cited by 473
E. Thiis-Evensen, G. S. H. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750026443 · Cited by 469
Relative frequency and morphology of cancers in carriers of germline TP53 mutations
Birch, J. M., Alston, R. D., McNally, R. J., Evans, D. G. R., Kelsey, A. M., Harris, M., Eden, O. B., & Varley, J. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204621 · Cited by 467
van den Belt-Dusebout, A. W., de Wit, R., Gietema, J. A., Horenblas, S., Louwman, M. W. J., Ribot, J. G., Hoekstra, H. J., Ouwens, G. M., Aleman, B. M. P., & van Leeuwen, F. E. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5296 · Cited by 453
Solid cancers after allogeneic hematopoietic cell transplantation
Rizzo, J. D., Curtis, R. E., Socié, G., Sobocinski, K. A., Gilbert, E., Landgren, O., Travis, L. B., Travis, W. D., Flowers, M. E. D., Friedman, D. L., et al. (2009) · Blood · doi:10.1182/blood-2008-05-158782 · Cited by 439
Self-citationNg, A. K., Bernardo, M. V. P., Weller, E., Backstrand, K., Silver, B., Marcus, K. C., Tarbell, N. J., Stevenson, M. A., Friedberg, J. W., & Mauch, P. M. (2002) · Blood · doi:10.1182/blood-2002-02-0634 · Cited by 433
Self-citationScreening for Cutaneous Melanoma by Skin Self-Examination
Berwick, M., Begg, C. B., Fine, J. A., Roush, G. C., & Barnhill, R. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.1.17 · Cited by 433
Cancer in the Contralateral Breast after Radiotherapy for Breast Cancer
Boice, J. D., Harvey, E. B., Blettner, M., Stovall, M., & Flannery, J. T. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261201 · Cited by 432
Ng, A. K., Bernardo, M. P., Weller, E., Backstrand, K. H., Silver, B., Marcus, K. C., Tarbell, N. J., Friedberg, J., Canellos, G. P., & Mauch, P. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.021 · Cited by 422
Self-citationMalignant neoplasms following bone marrow transplantation
Bhatia, S., Ramsay, N., Steinbuch, M., Dusenbery, K., Shapiro, R., Weisdorf, D., Robison, L., Miller, J., & Neglia, J. (1996) · Blood · doi:10.1182/blood.v87.9.3633.bloodjournal8793633 · Cited by 410
Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia
Witherspoon, R. P., Fisher, L. D., Schoch, G., Martin, P., Sullivan, K. M., Sanders, J., Deeg, H. J., Doney, K., Thomas, D., Storb, R., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909213211203 · Cited by 409
Cancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
Landgren, O., Gilbert, E. S., Rizzo, J. D., Socié, G., Banks, P. M., Sobocinski, K. A., Horowitz, M. M., Jaffe, E. S., Kingma, D. W., Travis, L. B., et al. (2009) · Blood · doi:10.1182/blood-2008-09-178046 · Cited by 400
Self-citationHowell, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74803-0 · Cited by 398
Sharif, S., Ferner, R., Birch, J. M., Gillespie, J. E., Gattamaneni, H. R., Baser, M. E., & Evans, D. G. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8349 · Cited by 377
Sigurdson, A. J., Ronckers, C. M., Mertens, A. C., Stovall, M., Smith, S. A., Liu, Y., Berkow, R. L., Hammond, S., Neglia, J. P., Meadows, A. T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66695-0 · Cited by 366
Pedersen-Bjergaard, J., Daugaard, G., Hansen, S. W., Rørth, M., Philip, P., & Larsen, S. O. (1991) · The Lancet · doi:10.1016/0140-6736(91)90490-g · Cited by 362
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
Stoffel, E., Mukherjee, B., Raymond, V. M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S., & Gruber, S. B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.039 · Cited by 360
Risk of Leukemia after Platinum-Based Chemotherapy for Ovarian Cancer
Travis, L. B., Holowaty, E. J., Bergfeldt, K., Lynch, C. F., Kohler, B. A., Wiklund, T., Curtis, R. E., Hall, P., Andersson, M., Pukkala, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400504 · Cited by 359
Self-citationA genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
Di Bernardo, M. C., Crowther-Swanepoel, D., Broderick, P., Webb, E., Sellick, G., Wild, R., Sullivan, K., Vijayakrishnan, J., Wang, Y., Pittman, A. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.219 · Cited by 357
Self-citationSecond malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch, J. F., Wexler, L. H., Marcus, R. B., Fairclough, D., Weaver-McClure, L., White, M., Mao, L., Delaney, T. F., Pratt, C. B., Horowitz, M. E., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2818 · Cited by 351
Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma
Hodgson, D. C., Gilbert, E. S., Dores, G. M., Schonfeld, S. J., Lynch, C. F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0936 · Cited by 351
Self-citationTherapy-Related Myeloid Leukemia
Godley, L. A., & Larson, R. A. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.012 · Cited by 347
The incidence of malignant melanoma in the United States: Issues as we approach the 21st century
Rigel, D. S., Friedman, R. J., & Kopf, A. W. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90041-9 · Cited by 345
Travis, L. B., Rabkin, C. S., Brown, L. M., Allan, J. M., Alter, B. P., Ambrosone, C. B., Begg, C. B., Caporaso, N., Chanock, S., DeMichele, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj001 · Cited by 342
Self-citationSecond Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk
Chaturvedi, A. K., Engels, E. A., Gilbert, E. S., Chen, B. E., Storm, H., Lynch, C. F., Hall, P., Langmark, F., Pukkala, E., Kaijser, M., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm201 · Cited by 341
Self-citationHannaford, P. C., Selvaraj, S., Elliott, A. M., Angus, V., Iversen, L., & Lee, A. J. (2007) · BMJ · doi:10.1136/bmj.39289.649410.55 · Cited by 337
Stovall, M., Smith, S. A., Langholz, B. M., Boice, J. D., Shore, R. E., Andersson, M., Buchholz, T. A., Capanu, M., Bernstein, L., Lynch, C. F., et al. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.02.040 · Cited by 329
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000238648.23538.42 · Cited by 329
Second Malignant Neoplasms: Assessment and Strategies for Risk Reduction
Wood, M. E., Vogel, V., Ng, A., Foxhall, L., Goodwin, P., & Travis, L. B. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.41.8681 · Cited by 323
Self-citationSolid Cancers After Bone Marrow Transplantation
Bhatia, S., Louie, A. D., Bhatia, R., O’Donnell, M. R., Fung, H., Kashyap, A., Krishnan, A., Molina, A., Nademanee, A., Niland, J. C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.464 · Cited by 316
Pedersen-Bjergaard, J., Pedersen, M., Roulston, D., & Philip, P. (1995) · Blood · doi:10.1182/blood.v86.9.3542.bloodjournal8693542 · Cited by 306
Testicular Cancer Survivorship: Research Strategies and Recommendations
Travis, L. B., Beard, C., Allan, J. M., Dahl, A. A., Feldman, D. R., Oldenburg, J., Daugaard, G., Kelly, J. L., Dolan, M. E., Hannigan, R., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq216 · Cited by 294
Self-citationBhatti, P., Veiga, L. H. S., Ronckers, C. M., Sigurdson, A. J., Stovall, M., Smith, S. A., Weathers, R., Leisenring, W., Mertens, A. C., Hammond, S., et al. (2010) · Radiation Research · doi:10.1667/rr2240.1 · Cited by 290
Krishnan, A., Bhatia, S., Slovak, M. L., Arber, D. A., Niland, J. C., Nademanee, A., Fung, H., Bhatia, R., Kashyap, A., Molina, A., et al. (2000) · Blood · doi:10.1182/blood.v95.5.1588.005k38_1588_1593 · Cited by 285
Parry, S., Win, A. K., Parry, B., Macrae, F. A., Gurrin, L. C., Church, J. M., Baron, J. A., Giles, G. G., Leggett, B. A., Winship, I., et al. (2011) · Gut · doi:10.1136/gut.2010.228056 · Cited by 285
Schoch, C., Kern, W., Schnittger, S., Hiddemann, W., & Haferlach, T. (2004) · Leukemia · doi:10.1038/sj.leu.2403187 · Cited by 284
Warner, E., Hill, K., Causer, P., Plewes, D., Jong, R., Yaffe, M., Foulkes, W. D., Ghadirian, P., Lynch, H., Couch, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0835 · Cited by 280
Hershman, D., Neugut, A. I., Jacobson, J. S., Wang, J., Tsai, W.-Y., McBride, R., Bennett, C. L., & Grann, V. R. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk028 · Cited by 279
Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
Chan, A. T., Arber, N., Burn, J., Chia, W. K., Elwood, P., Hull, M. A., Logan, R. F., Rothwell, P. M., Schrör, K., & Baron, J. A. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0391 · Cited by 276
Smith, R. A., Cokkinides, V., Brooks, D., Saslow, D., Shah, M., & Brawley, O. W. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20096 · Cited by 275
Mauritzson, N., Albin, M., Rylander, L., Billström, R., Ahlgren, T., Mikoczy, Z., Björk, J., Strömberg, U., Nilsson, P., Mitelman, F., et al. (2002) · Leukemia · doi:10.1038/sj.leu.2402713 · Cited by 269
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
Freedman, A. N., Seminara, D., Gail, M. H., Hartge, P., Colditz, G. A., Ballard-Barbash, R., & Pfeiffer, R. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji128 · Cited by 267
Treatment-Associated Leukemia Following Testicular Cancer
Travis, L. B. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1165 · Cited by 254
Self-citationRisks of Primary Extracolonic Cancers Following Colorectal Cancer in Lynch Syndrome
Win, A. K., Lindor, N. M., Young, J. P., Macrae, F. A., Young, G. P., Williamson, E., Parry, S., Goldblatt, J., Lipton, L., Winship, I., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs351 · Cited by 254
Kirova, Y. M., Vilcoq, J. R., Asselain, B., Sastre‐Garau, X., & Fourquet, A. (2005) · Cancer · doi:10.1002/cncr.21223 · Cited by 251
Therapy-related leukemia and myelodysplasia: susceptibility and incidence
Leone, G., Pagano, L., Ben-Yehuda, D., & Voso, M. T. (2007) · Haematologica · doi:10.3324/haematol.11034 · Cited by 236
Roles of Radiotherapy and Smoking in Lung Cancer Following Hodgkin's Disease
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Hagenbeek, A., van den Belt-Dusebout, A. W., Noyon, R., Boice, J. D., Burgers, J. M. V., & Somers, R. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1530 · Cited by 234
Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
Travis, L. B., Ng, A. K., Allan, J. M., Pui, C.-H., Kennedy, A. R., Xu, X. G., Purdy, J. A., Applegate, K., Yahalom, J., Constine, L. S., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr533 · Cited by 229
Self-citationMajhail, N. S., Brazauskas, R., Rizzo, J. D., Sobecks, R. M., Wang, Z., Horowitz, M. M., Bolwell, B., Wingard, J. R., & Socie, G. (2011) · Blood · doi:10.1182/blood-2010-07-294629 · Cited by 223
Second Cancer Risk After Chemotherapy for Hodgkin's Lymphoma: A Collaborative British Cohort Study
Swerdlow, A. J., Higgins, C. D., Smith, P., Cunningham, D., Hancock, B. W., Horwich, A., Hoskin, P. J., Lister, T. A., Radford, J. A., Rohatiner, A. Z. S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.8268 · Cited by 222
Preventive therapy for breast cancer: a consensus statement
Cuzick, J., DeCensi, A., Arun, B., Brown, P. H., Castiglione, M., Dunn, B., Forbes, J. F., Glaus, A., Howell, A., von Minckwitz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70030-4 · Cited by 220
Cancer pharmacogenomics: strategies and challenges
Wheeler, H. E., Maitland, M. L., Dolan, M. E., Cox, N. J., & Ratain, M. J. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3352 · Cited by 215
Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.-X., Foo, J. N., McLaren, P. J., Li, Z., Yang, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002791 · Cited by 210
BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
Purnomosari, D., Pals, G., Wahyono, A., Aryandono, T., Manuaba, T. W., Haryono, S. J., & van Diest, P. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9493-4 · Cited by 197
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00539 · Cited by 195
Friedman, D. L., Rovó, A., Leisenring, W. M., Locasciulli, A., Flowers, M. E. D., Tichelli, A., Sanders, J. E., Deeg, H. J., & Socié, G. (2007) · Blood · doi:10.1182/blood-2007-07-099283 · Cited by 194
DNA Damage Responses: Mechanisms and Roles in Human Disease
Kastan, M. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0020 · Cited by 189
Nonmelanoma Skin and Mucosal Cancers After Hematopoietic Cell Transplantation
Leisenring, W., Friedman, D. L., Flowers, M. E. D., Schwartz, J. L., & Deeg, H. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7052 · Cited by 185
Lyman, G. H., Dale, D. C., Wolff, D. A., Culakova, E., Poniewierski, M. S., Kuderer, N. M., & Crawford, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8723 · Cited by 181
Morrison, V. A., Rai, K. R., Peterson, B. L., Kolitz, J. E., Elias, L., Appelbaum, F. R., Hines, J. D., Shepherd, L., Larson, R. A., & Schiffer, C. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.128 · Cited by 176
Risk of Second Malignancy After Non-Hodgkin's Lymphoma: A British Cohort Study
Mudie, N. Y., Swerdlow, A. J., Higgins, C. D., Smith, P., Qiao, Z., Hancock, B. W., Hoskin, P. J., & Linch, D. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2200 · Cited by 172
Bairati, I., Meyer, F., Jobin, E., Gélinas, M., Fortin, A., Nabid, A., Brochet, F., & Têtu, B. (2006) · International Journal of Cancer · doi:10.1002/ijc.22042 · Cited by 171
Hewitt, M. E., & Ganz, P. (2006) · Cited by 169
Effect of Breast Cancer Radiotherapy and Cigarette Smoking on Risk of Second Primary Lung Cancer
Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.3033 · Cited by 169
Best, T., Li, D., Skol, A. D., Kirchhoff, T., Jackson, S. A., Yasui, Y., Bhatia, S., Strong, L. C., Domchek, S. M., Nathanson, K. L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2407 · Cited by 168
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT
Milligan, D. W., Ruiz de Elvira, M. C., Kolb, H., Goldstone, A. H., Meloni, G., Rohatiner, A. Z., Colombat, P., & Schmitz, N. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01627.x · Cited by 167
Secondary Gastrointestinal Cancer in Childhood Cancer Survivors: A Cohort Study
Henderson, T. O., Oeffinger, K. C., Whitton, J., Leisenring, W., Neglia, J., Meadows, A., Crotty, C., Rubin, D. T., Diller, L., Inskip, P., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00002 · Cited by 165
Do, K.-A., Johnson, M. M., Doherty, D. A., Lee, J. J., Wu, X. F., Dong, Q., Hong, W. K., Khuri, F. R., Fu, K. K., & Spitz, M. R. (2003) · Cancer Causes & Control · doi:10.1023/a:1023060315781 · Cited by 163
Therapy-associated Solid Tumors
Travis, L. B. (2002) · Acta Oncologica · doi:10.1080/028418602760169361 · Cited by 163
Self-citationRadiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment
Rubino, C., Shamsaldin, A., L�, M. G., Labb�, M., Guinebreti�re, J.-M., Chavaudra, J., & de Vathaire, F. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-2472-8 · Cited by 158
Referral for cancer genetics consultation: a review and compilation of risk assessment criteria
Hampel, H., Sweet, K., Westman, J. A., Offit, K., & Eng, C. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.010918 · Cited by 158
The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
Metcalfe, K. A., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I. A., Foulkes, W. D., Warner, E., Olopade, O. I., Eisen, A. F., Weber, B., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.09.039 · Cited by 157
Armstrong, G. T., Liu, W., Leisenring, W. M., Yasui, Y., Hammond, S., Bhatia, R., Neglia, J. P., Stovall, M., Srivastava, D. K., & Robison, L. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.6585 · Cited by 157
Two metachronous tumors in the radiotherapy fields of a patient with Li‐Fraumeni syndrome
Limacher, J., Frébourg, T., Natarajan‐Amé, S., & Bergerat, J. (2001) · International Journal of Cancer · doi:10.1002/ijc.1021 · Cited by 151
Bernstein, J. L., Haile, R. W., Stovall, M., Boice, J. D., Shore, R. E., Langholz, B. M., Thomas, D. C., Bernstein, L., Lynch, C. F., Olsen, J. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq055 · Cited by 151
André, M. P. E. (2003) · Blood · doi:10.1182/blood-2003-04-1124 · Cited by 151
Li, C. I., Daling, J. R., Porter, P. L., Tang, M.-T. C., & Malone, K. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.1597 · Cited by 145
Therapy‐related myeloid neoplasms: pathobiology and clinical characteristics
Sill, H., Olipitz, W., Zebisch, A., Schulz, E., & Wölfler, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01100.x · Cited by 144
Brodin, N. P., af Rosenschöld, P. M., Aznar, M. C., Kiil-Berthelsen, A., Vogelius, I. R., Nilsson, P. G., Lannering, B., & Björk‐Eriksson, T. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.582514 · Cited by 144
Rhiem, K., Engel, C., Graeser, M., Zachariae, S., Kast, K., Kiechle, M. B., Ditsch, N. C., Janni, W. J., Mundhenke, C., Golatta, M., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3369 · Cited by 137
Radiation-sensitive genetically susceptible pediatric sub-populations
Kleinerman, R. A. (2008) · Pediatric Radiology · doi:10.1007/s00247-008-1015-6 · Cited by 135
IRF4 Variants Have Age-Specific Effects on Nevus Count and Predispose to Melanoma
Duffy, D. L., Iles, M. M., Glass, D., Zhu, G., Barrett, J. H., Höiom, V., Zhao, Z., Sturm, R. A., Soranzo, N., Hammond, C. J., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2010.05.017 · Cited by 134
Breast cancer risk factors and second primary malignancies among women with breast cancer
Trentham‐Dietz, A., Newcomb, P. A., Nichols, H. B., & Hampton, J. M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9446-y · Cited by 133
Chemotherapy and Thyroid Cancer Risk: A Report from the Childhood Cancer Survivor Study
Veiga, L. H. S., Bhatti, P., Ronckers, C. M., Sigurdson, A. J., Stovall, M., Smith, S. A., Weathers, R. E., Leisenring, W. M., Mertens, A. C., Hammond, S., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0576 · Cited by 131
Randomized trial of supplemental beta-carotene to prevent second head and neck cancer.
Mayne, S. T., Cartmel, B., Baum, M. K., Shor‐Posner, G., Fallon, B. G., Briskin, K. B., Bean, J. A., Zheng, T., COOPER, D. L., Friedman, C. D., et al. (2001) · PubMed · Cited by 130
Henderson, T. O., Rajaraman, P., Stovall, M. A., Constine, L. S., Olive, A. M., Smith, S. A., Mertens, A. C., Meadows, A. T., Neglia, J. P., Hammond, S., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.11.022 · Cited by 129
Lin, K., Patel, S. G., Chu, P. Y., Matsuo, J. M. S., Singh, B., Wong, R. J., Kraus, D. H., Shaha, A. R., Shah, J. P., & Boyle, J. O. (2005) · Head & Neck · doi:10.1002/hed.20272 · Cited by 125
Jarlskog, C. Z., & Paganetti, H. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.04.069 · Cited by 121
Reiner, A. S., John, E. M., Brooks, J. D., Lynch, C. F., Bernstein, L., Mellemkjær, L., Malone, K. E., Knight, J. A., Capanu, M., Teraoka, S. N., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.2013 · Cited by 119
Secondary Colorectal Carcinoma After Childhood Cancer
Nottage, K. A., McFarlane, J. J., Krasin, M. J., Li, C., Srivastava, D. K., Robison, L. L., & Hudson, M. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8760 · Cited by 118
3–14 The Risk of Ovarian Cancer After Breast Cancer in BRCA1 and BRCA2 Carriers
Lu, K. H. (2005) · Breast Diseases A Year Book Quarterly · doi:10.1016/s1043-321x(05)80198-5 · Cited by 115
Berwick, M., Orlow, I., Hummer, A., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton‐Culver, H., Zanetti, R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0270 · Cited by 114
Second cancers after medulloblastoma: population-based results from the United States and Sweden
Goldstein, A. M., Yuen, J. E., & Tucker, M. A. (1997) · Cancer Causes & Control · doi:10.1023/a:1018464328836 · Cited by 112
Landier, W., Armenian, S. H., Lee, J., Thomas, O., Wong, F. L., Francisco, L., Herrera, C., Kasper, C., Wilson, K. D., Zomorodi, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4951 · Cited by 109
Bhojani, N., Umberto Capitanio, A., Suardi, N. R., Claudio Jeldres, A., Hendrik Isbarn, A., Shariat, S. F., Graefen, M., Arjane, P., Duclos, A. J., Lattouf, J., et al. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.011 · Cited by 105
Roles of Radiation Dose and Chemotherapy in the Etiology of Stomach Cancer as a Second Malignancy
van den Belt‐Dusebout, A. W., Aleman, B. M. P., Besseling, G., Bruin, M. L. D., Hauptmann, M., Veer, M. B. V., de Wit, R., Ribot, J. G., Noordijk, E. M., Kerst, J. M., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.01.073 · Cited by 97
León, X., Venegas, M. D. P., Orús, C., López, M., Garcı́a, J., & Quer, M. (2008) · Cancer Causes & Control · doi:10.1007/s10552-008-9277-8 · Cited by 95
Zablotska, L. B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi050 · Cited by 94
Incidence of Invasive Cancers Following Squamous Cell Skin Cancer
Levi, F., Randimbison, L., Vecchia, C. L., Erler, G., & Te, V.-C. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009349 · Cited by 94
Secondary malignant neoplasms after Wilms tumor: An international collaborative study
Breslow, N. E., Lange, J. M., Friedman, D. L., Green, D. M., Hawkins, M., Murphy, M. F. G., Neglia, J. P., Olsen, J. H., Peterson, S. M., Stiller, C. A., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25067 · Cited by 92
Second solid cancers after allogeneic hematopoietic stem cell transplantation
Gallagher, G., & Forrest, D. L. (2006) · Cancer · doi:10.1002/cncr.22375 · Cited by 92
Claßen, J., Schmidberger, H., Meisner, C., Winkler, C., Dunst, J., Souchon, R., Weißbach, L., Budach, V., Alberti, W., & BAMBERG, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601867 · Cited by 90
Advances in the understanding of susceptibility to treatment‐related acute myeloid leukaemia
Seedhouse, C., & Russell, N. H. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06613.x · Cited by 79
Increased risk of colon cancer after external radiation therapy for prostate cancer
Rapiti, E., Fioretta, G., Verkooijen, H. M., Zanetti, R., Schmidlin, F. R., Schubert, H., Merglen, A., Miralbell, R., & Bouchardy, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23601 · Cited by 77
Cancer risk in women with previous breast cancer
Levi, F., Te, V.-C., Randimbison, L., & Vecchia, C. L. (2002) · Annals of Oncology · doi:10.1093/annonc/mdg028 · Cited by 76
Management of familial melanoma
Newton‐Bishop, J., Harland, M., Randerson‐Moor, J. A., & Bishop, D. T. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)71010-5 · Cited by 69
Hereditary Nonpolyposis Colon Cancer
Rusin, L. C., & Galandiuk, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-36374-5_38 · Cited by 67
Elena, J. W., Travis, L. B., Simonds, N. I., Ambrosone, C. B., Ballard-Barbash, R. R., Bhatia, R., Cerhan, J. R., Hartge, P. A., Heist, R. S., Kushi, L. H., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs473 · Cited by 65
Self-citationRisk of metachronous breast cancer after BRCA mutation–associated ovarian cancer
Domchek, S. M., Jhaveri, K. L., Patil, S. N., Stopfer, J. E., Hudis, C. A., Powers, J. M., Stadler, Z. K., Goldstein, L., Kauff, N. D., Khasraw, M., et al. (2012) · Cancer · doi:10.1002/cncr.27842 · Cited by 63
CASTIGLIANO, S. G. (1968) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1968.0275 · Cited by 61
Myelodysplastic Syndromes Arising in Patients With Germline TP53 Mutation and Li-Fraumeni Syndrome
Talwalkar, S. S., Yin, C. C., Naeem, R. C., Hicks, J. M., Strong, L. C., & Abruzzo, L. V. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2009-0015-oa.1 · Cited by 60
Mauch, P., Ng, A. K., Aleman, B. M. P., Carde, P. P., Constine, L. S., Diehl, V., Dinshaw, K. A., Gospodarowicz, M. K., Hancock, S., Hodgson, D. C., et al. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00458.x · Cited by 55
Self-citationSecond cancers after testicular cancer diagnosed after 1980 in Sweden
Hemminki, K., Liu, H., & Sundquist, J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp562 · Cited by 55
Breast cancer susceptibility—A new look at an old model
Peto, J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00079-x · Cited by 51
Subsequent Malignant Neoplasms after Hematopoietic Cell Transplantation
Socié, G., Baker, K. S., & Bhatia, R. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.10.005 · Cited by 51
Bhatia, R. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0659 · Cited by 45
Nutting, C. M., Camplejohn, R., Gilchrist, R., Tait, D., Blake, P., Knee, G., Yao, W. Q., Ross, G., Fisher, C., & Eeles, R. A. (2000) · Clinical Oncology · doi:10.1053/clon.2000.9179 · Cited by 44
Freedman, A. N., Sansbury, L. B., Figg, W. D., Potosky, A. L., Smith, S. R. W., Khoury, M. J., Nelson, S. A., Weinshilboum, R. M., Ratain, M. J., McLeod, H. L., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq390 · Cited by 43
Hernández‐Boluda, J. C., Pereira, A., Cervantes, F., Álvarez‐Larrán, A., Collado, M., Such, E., Arilla, M.-J., Boqué, C., Xicoy, B., Maffioli, M., et al. (2012) · Blood · doi:10.1182/blood-2012-02-411215 · Cited by 42
Poor Survival of Treatment-Related Acute Nonlymphocytic Leukemia
Neugut, A. I., Robinson, E., Nieves, J., Murray, T., & Tsai, W. Y. (1990) · JAMA · doi:10.1001/jama.1990.03450080092038 · Cited by 40
Bladder cancer in cancer patients: population-based estimates from a large Swedish study
Bermejo, J. L., Sundquist, J., & Hemminki, K. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605325 · Cited by 38
Majed, B., Dozol, A., Ribassin-Majed, L., Senouci, K., & Asselain, B. J. R. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1153-z · Cited by 36
Patterns of subsequent malignancies after H odgkin lymphoma in children and adults
Omer, B. A., Kadan‐Lottick, N. S., Roberts, K. B., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09211.x · Cited by 34
Risk factors for second primary tumours in breast cancer survivors
Sánchez, L., Lana, A., Hidalgo, A., Rodríguez, J. M., Valle, M. O. D., Cueto, A., Folgueras, M., Belyakova, E., Comendador, M. A., & López, M. L. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282f75ee5 · Cited by 32
Choi, G., Huang, B. Z., Pinarbasi, E. S., Braunstein, S. E., Horvai, A., Kogan, S. C., Bhatia, R., Faddegon, B., & Nakamura, J. L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1728 · Cited by 30
GENETIC SUSCEPTIBILITY TO RADIOGENIC CANCER IN HUMANS
Allan, J. M. (2008) · Health Physics · doi:10.1097/01.hp.0000326339.06405.ea · Cited by 22
Self-citationLong-Term Outcomes of Myeloid Growth Factor Treatment
Lyman, G. H., & Dale, D. C. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0077 · Cited by 16
Interaction of CDKN2A and Sun Exposure in the Etiology of Melanoma in the General Population
Berwick, M., Begg, C. B., Armstrong, B. K., Reiner, A. S., Thomas, N. E., Cook, L. S., Orlow, I., Kricker, A., Marrett, L. D., Gruber, S. B., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.235 · Cited by 9
Cited by
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Annese, V., Beaugerie, L., Egan, L., Biancone, L., Bolling, C., Brandts, C., Dierickx, D., Dummer, R., Fiorino, G., Gornet, J. M., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv141 · Cited by 428
New insights into the activities and toxicities of the old anticancer drug doxorubicin
van der Zanden, S. Y., Qiao, X., & Neefjes, J. (2021) · The FEBS Journal · doi:10.1111/febs.15583 · Cited by 410
Radiation induced secondary malignancies: a review article
Dracham, C. B., Shankar, A., & Madan, R. (2018) · Radiation Oncology Journal · doi:10.3857/roj.2018.00290 · Cited by 349
Practical clinical interventions for diet, physical activity, and weight control in cancer survivors
Demark‐Wahnefried, W., Rogers, L. Q., Alfano, C. M., Thomson, C. A., Courneya, K. S., Meyerhardt, J. A., Stout, N. L., Kvale, E., Ganzer, H., & Ligibel, J. A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21265 · Cited by 251
Ryder-Burbidge, C., Diaz, R. L., Barr, R. D., Gupta, S., Nathan, P. C., McKillop, S. J., & Fidler-Benaoudia, M. M. (2021) · Cancers · doi:10.3390/cancers13194870 · Cited by 65
Metadata
- Authors
- Travis, L. B., Wahnefried, W. D., Allan, J. M., Wood, M. E., & Ng, A. K.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2013-03-26
- Volume
- 10
- Issue
- 5
- Pages
- 289-301
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2048428090
- Cited by
- 264
- References
- 183
- FWCI
- 2.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.